News & Events
2024 Avoca Industry Survey
The survey is now closed — thank you for your participation!
Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey focuses on potential changes in regulatory guidance under ICH E6 (R3). Importantly, you don’t need to be familiar […]
Webinar: ICH E6(R3) Essentials: A Draft Guidance Overview
February 6, 2024 | 1:30pm – 3:00pm EST
Have confidence that you’re ready for successful implementation of the final R3 guidance.
AQC Member-only Webinar
January 17, 2024 | 11:00am – 12:30pm EST
The AQC is excited to kick off 2024 with a member-only meeting.
Book: Tracking the Revised ICH E6
A Side-by-Side Comparison of Revisions 2 and 3 Changes to the international guideline for good clinical practice, ICH E6, are extensive, significant and scheduled to take effect in less than a year. Are you prepared to understand and implement them? ICH E6(R3), as currently published, is a completely revised guideline with no reference to […]
Read MoreArticle: Report Reveals Trial Enrollment Drivers, Distrust of Pharmaceutical Co. Sponsors
Health Care Compliance Association (HCCA) Report on Research Compliance Volume 20, Number 10 September 21, 2023 By Theresa Defino It’s not surprising that most people don’t hold informed—or strong beliefs about clinical trials—they’re what is termed “research-naïve,” meaning they have little or no personal experience with them. And so are most providers. […]
Read MoreWCG Talks Trials Podcast: Episode 3 – A 360-degree View on Motivators and Deterrents to Clinical Trial Participation
Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients.
Read More